Pieris Pharmaceuticals (NASDAQ:PIRS) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS opened at $0.24 on Friday. Pieris Pharmaceuticals has a 12-month low of $0.16 and a 12-month high […]
More Stories
ProShares Short VIX Short-Term Futures ETF (BATS:SVXY) Trading Down 1% – Here’s Why
Shares of ProShares Short VIX Short-Term Futures ETF (BATS:SVXY – Get Free Report) were down 1% during trading on Tuesday...
Biotech Acquisition (OTCMKTS:BIOTU) Trading Down 7.7% – Time to Sell?
Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report)’s stock price was down 7.7% during trading on Tuesday . The company traded...
Forafric Global (NASDAQ:AFRI) Stock Price Down 0.3% – What’s Next?
Forafric Global PLC (NASDAQ:AFRI – Get Free Report) was down 0.3% during mid-day trading on Tuesday . The company traded...
Darktrace (OTC:DRKTF) Shares Down 60.6% – Here’s What Happened
Shares of Darktrace plc (OTC:DRKTF – Get Free Report) dropped 60.6% during trading on Tuesday . The stock traded as...
Suspect in Explosion Outside Trump’s Las Vegas Hotel Identified as Special Forces Soldier
By Katabella Roberts and Ryan Morgan Investigators have identified the individual who died inside a Tesla Cybertruck filled with explosives...
Nagarro (OTCMKTS:NGRRF) Stock Price Down 2.9% – Time to Sell?
Shares of Nagarro SE (OTCMKTS:NGRRF – Get Free Report) fell 2.9% during mid-day trading on Tuesday . The stock traded...